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Summary.-Terminal deoxynucleotidyl transferase (TdT) was estimated in the
tissues of 42 patients with lymphoma, whose cells were also typed by the use of
surface markers. Four of the 8 patients with T-cell lymphoma were TdT+ including
patients whose lymph nodes showed an undifferentiated or poorly differentiated
appearance. The TdT- T-cell lymphomas included cases with diffuse histiocytic,
Sezary cell, diffuse, poorly differentiated and angio-immunoblastic histology.
The tissues of 31 patients with B-cell lymphoma were invariably TdT-, whether
the histology was poorly differentiated, well differentiated, nodular, diffuse, histio-
cytic or Burkitt type, and including cases with about equal proportions of T and B
cells, and thosewhosecells showednon-capping and cappingsurfaceimmunoglobulin.
Hodgkin's tissue was also invariably TdT-. We conclude that estimation of TdT in
tissues of patients with malignant lymphoma may be a useful test in diagnosing the
T-cell lymphoma, particularly in patients with tumours of undifferentiated or poorly
differentiated histology.
TERMINAL deoxynucleotidyl transferase
(TdT) is an enzyme normally present in
human marrow and thymus. The enzyme
is present in 1-5% of murine marrow cells
(Pazmino et al., 1977) and is restricted to
the immature cortisone-sensitive fraction
of thymic lymphocytes. The enzyme has
also been found in the cells of patients
with non-T, non-B, acute lymphoblastic
leukaemia (ALL), T-cell ALL, and of
some patients with blast transformation
of chronic granulocytic leukaemia (CGL),
but is usually absent in other types of
leukaemia (McCaffrey et al., 1973;
1975; Coleman et al., 1974, 1976; Sarin
et al., 1976; Hoffbrand et al., 1977). It
appears therefore that the enzyme
is present in the pluripotential marrow
stem cell and is lost as cells mature
down the myeloid or lymphoid pathways,
being retained only in thymocytes. In
lymphoma, TdT has only been detected in
tumours of "lymphoblastic" histology
(Donlon et al., 1977; Kung et al., 1978). In
the present study we report the TdT
activity in the tissues of patients with
lymphoma in which the surface phenotype
of the cells has been established by tests
ofsheep-cell rosettes and surface immuno-
globulinandcomplement(C3)receptorsand
by antibodies to non-B, non-T ALL (anti-
ALL), to T-ALL (anti-HTLA), and the Ia
antigen. The results show that the more
common B-cell lymphomas and Hodgkin's
tissues are normally TdT- whereas some
but not all T-cell lymphomas are TdT+.
PATIENTS, MATERIALS AND METHODS
Material consisted of tumour-cell popula-
tions obtained from lymph nodes (36), tonsil
(1), spleen (1), marrow (2), pleural effusion
(2) and blood (1) in 42 patients with malignant
lymphoma. In one patient with angio-
immunoblastic lymphoma, studies were done
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on biopsy specimens performed on two
different occasions from different sites. All
specimens were totally replaced or heavily
infiltrated with tumour cells. Control tissue
from tonsil, peripheral blood, reactive lymph
nodes (one with follicular hyperplasia, one
showing sarcoid reaction) and adult thymus
and tumour from a case ofneuroblastoma was
also tested. After mononuclear cell separation,
the cells in each case were surface-marked
using sheep erythrocytes for E, using ox red
cells for Fe and C3 receptors, and for surface-
membrane immunoglobulin (SIg). Using poly-
valent anti-human G, M and A heavy-chain
antisera, the proportions of capping and non-
capping cells were determined after appro-
priate incubation (Habeshaw et al., 1977).
Specific antisera against G, M, A, and D
heavy chains, and K and LJ light chains were
used to determine class of SIg and cytoplas-
mic immunoglobulin (CyIg). Null cells were
further characterized using antisera to ALL
antigen, T-cell antigen (HTLA), and Ia-like
antigen (Ia), the gift of Dr M Greaves and
Dr G. Janossy (ICRF Laboratories, Lincoln's
Inn Fields). Phagocytes were quantitated by
tests for ingestion of neutral red andparticles
oflatex. None ofthe cases showed substantial
macrophage populations. The appropriate
histological diagnosis was available in each
case, and was grouped according to the
Rappaport classification: diffuse undifferenti-
ated (DU or lymphoblastic), diffuse histio-
cytic (DH), diffuse poorly differentiated
(DPD), nodular poorly differentiated (NPD),
nodular and diffuse poorly differentiated
(N+DPD), and diffuse well differentiated
(DWD). One case conformed to the descrip-
tion of angio-immunoblastic lymphadeno-
pathy (AIL) but showed monoclonal SIg and
CyIg in the two biopsy specimens (tonsil and
cervical node). One other case remained un-
classified. Hodgkin's nodes from 4 cases were
classified according to the Rye classification
as nodular sclerosing (1 case) or lymphocytic
predominant (3 cases). The cells remaining
after determination ofthe profile (usually 108
viable cells) were centrifuged into a pellet,
quickly frozen in C02, and stored at -40°C
for up to 3 weeks before TdT estimation as
previously described (Hoffbrand et al., 1977).
RESULTS
Control tissues
TdT levels in control tissues ranged
from 0 0 to 14 u/108 cells (tonsil I 1, blood
05, reactive nodes (2) 0 0, neuroblastoma
01). In one positive control thymus the
TdT level was 117 0 U/l08 cells.
Hodgkin's disease
In 4 Hodgkin's disease lymph nodes,
TdT levels ranged from 0-2 to 1-3 U/108
cells (3 lymphocyte predominant, and 1
nodular sclerosing histology). All 4 showed
T-cell predominance (E+ 43-63%) with an
accompanying polyclonal B cell popula-
tion (18%-29% SIg+).
TdT+ tumours
Fourpatientsshowed TdT levels ranging
from 6-6 to 51 U/108 cells in the biopsied
tissues (Table I). The only adult (Case 4)
had a lesion containing numerous epithelial
TABLE I.-TdT+ cell lymphomas
Case Age/Sex Histology
1
2
3
4
6/M DU
9/F DPD
11/M DU
31/M Unclassi-
fied
Surface-
marker
profile
E SIg
+--
TdT
(u/108 cells)
51-0
27-2
8-6
6-6
histiocytes and small granulomata, with
some eosinophil infiltration in lymph node
and spleen. The histological appearances
were not considered typical of either
lymphoma or Hodgkin's disease. The sur-
face markers indicated a T-cell neoplasm
(E+, HTLA+, Ia-) in all 4 and 3 showed
mediastinal widening on X-ray.
TdT- T-cell tumours
Four patients in this series had tumours
composed of T cells (90% of cells) in
which TdT levels were not elevated
(Table II). Case 5 had a diffuse histiocytic
lymphoma and also showed an increased
number of T cells in the blood. Case 6 had
Sezary-cell lymphoma, with a leukaemic
blood picture and numerous circulating
Sezary cells. Case 7 had a diffuse lymph-
oma composed ofconvoluted lymphocytes,
and the cells present marked E+C3+SIg-.
In contrast to cases of similar phenotype
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TABLE II.-TdT- T-cell lym
Case Age/Sex Histology
5
6
7
8
Adult/F
Adult/M
4/M
Adult/M
DH
"Sezary
cell"
DU
AIL
Surface
marker
profile
E SIg
+
+ -, Ce,
+ - and
- Cylg+
(T cells with C3 receptors) desi
Kung et al. (1978) which were I
patient was TdT-. Case 8 hE
immunoblastic lymphadenopath
ing tonsil and cervical nodes. C
tonsils marked E+SIg- but a m
B-cell population ofCylg+ cells e
IgG with L chain was also prese
II). In the nodes T cells wer
tionately less, and the B cells
monoclonal SIg (Table III). Tdr
elevated in either tissue.
B-cell tumours
The remaining tumours were
mainly (over 80%) or entirely
expressing monoclonal surface
globin (Table III). TdT was i
normal in the tissues of these pa
eluding 4 who showed a substa
portion (up to 50%) of T cells
immunoglobulinmaybe"capping
capping" according to whether
formed on incubation over a
period. Non-capping tumours
posed of large cells, which ar
Fc-C3- and CyIg-. Capping
often, but not invariably, expre;
Kphomas or C3 receptors (Slg+Fc+C3+, Slg+C3+).
Non-capping tumours in general have a
TdT poorer prognosis, and frequently show
(U/108 cells) primitive histology, and are thought to be
0.0 derived from early cells in the B-cell line
0.4 of differentiation (Habeshaw et al., 1977).
Nevertheless, these cells were always
3 07 TdT-.
0.0
DISCUSSION
Terminal deoxynucleotidyl transferase
cribed by is now recognised as a marker of un-
PdT+, this differentiated marrow cells and immature
ad angio- T cells. The results here confirm that,
iy involv- among the lymphomas, only those derived
ells in the from immature T cells contain the enzyme.
Lonoclonal B-cell tumours were invariably TdT-.
Ixpressing One TdT+ SIg+ B-cell lymphoblastic
3nt (Table leukaemia has been described (Shaw et al.,
e propor- 1978). TdT was also detected in the cells
expressed of a patient with pre-B-cell lymphoblastic
F was not leukaemia (Vogler et al., 1978). As in pre-
viously published reports (Donlon et al.,
1977; Kung et al., 1978), we have found
TdT activity to occur in undifferentiated
composed lymphomas of T-cell type. The phenotype
of B cells of these tumours corresponds to those
immuno- described for T-ALL (E+HTLA+la-)
invariably (Greaves et al., 1977). One of our tumours
Ltients, in- of T cells, classified histologically as
Lntial pro- diffuse poorly differentiated lymphocytic
s. Surface lymphoma, was also TdT+ (Case 2). The
"org"non- TdT- T-cell lymphomas showed a variety
caps are of histology; one was undifferentiated.
i 20 min In the data of Kung et al. (1978) several
are com- cases of E+C3+ T-cell tumours with TdT
re usually positivity are described. In the single case
tumours presented here with this surface pheno-
ss Fc and/ type, the tumour was TdT-.
TABLE III.-B-cell lymphomna
No. of No. No. Adult/ Surface-marker
Histology cases capping Male profile
SIg C3 Fc
(1) NPD
(2) N+DPD
(3) DWD
(4) DPD
(5) DH
(6) AIL
(7) Burkitt
10
3
5
4
7
1
1
10
3
5
4
3
1
0
10/7
3/2
5/4
4/3
6/4
1/1
0/1
+F
+
+
+
2 cases in (1) 1 case in (3) 1 case in (6) showed mixed (approximately equal) E+ and Sg±+.
- CyIg ±
TdT range
(u/108 cells)
0 0-0 5
0-0-0-1
0-0-0 6
0-0-0-1
0 0-0 2
1-2
0-1
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Our failure to find TdT activity in
B-cell lymphomas of all histological types
corresponds to previously published find-
ings (Donlon et al., 1977; Kung et al.,
1978). Lymphomas of SIg+ cells seem to
be derived from differentiated, immuno-
logically competent B-cell populations.
Lymphomas expressing SIg and C3d re-
ceptors are derived from germinal centre
B lymphocytes (Stein et al., 1978). Cap-
ping SIg+ B cells including those with
cytoplasmic Ig are associated with medul-
lary-cord lymphocytes in normal nodes,
and the phenotype Slg+Fc+C3+ may
characterize the "virgin" B-cell popula-
tion. Non-capping Slg+Fc-C3- tumours
suggest a primitive or "transformed"
B-cell tumour. The fact that lymphoid
tumours expressing these phenotypes are
all TdT- suggests TdT is lost early in
B-cell differentiation.
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